AMETEK (NYSE:AME - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 7.020-7.180 for the period, compared to the consensus estimate of 7.080. The company issued revenue guidance of -.
AMETEK Stock Up 1.7 %
AME traded up $2.93 during trading on Friday, reaching $170.19. The company had a trading volume of 203,341 shares, compared to its average volume of 1,404,345. The company has a market cap of $39.27 billion, a P/E ratio of 28.70, a PEG ratio of 2.73 and a beta of 1.14. AMETEK has a 12 month low of $145.02 and a 12 month high of $198.33. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.24 and a quick ratio of 0.75. The business's fifty day moving average price is $170.50 and its 200 day moving average price is $179.35.
AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The technology company reported $1.75 EPS for the quarter, beating the consensus estimate of $1.69 by $0.06. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. The business had revenue of $1.73 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same period in the previous year, the firm posted $1.64 EPS. The firm's revenue was down .2% compared to the same quarter last year. Equities analysts anticipate that AMETEK will post 7.15 EPS for the current year.
AMETEK Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Friday, March 14th were given a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.24 dividend on an annualized basis and a yield of 0.73%. This is an increase from AMETEK's previous quarterly dividend of $0.28. AMETEK's dividend payout ratio is 20.91%.
AMETEK announced that its board has initiated a share buyback plan on Friday, February 7th that allows the company to repurchase $1.25 billion in outstanding shares. This repurchase authorization allows the technology company to purchase up to 2.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued.
Analyst Ratings Changes
AME has been the subject of a number of analyst reports. Robert W. Baird decreased their target price on shares of AMETEK from $200.00 to $197.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Truist Financial lowered their target price on AMETEK from $216.00 to $196.00 and set a "buy" rating on the stock in a research report on Tuesday, April 8th. StockNews.com cut AMETEK from a "buy" rating to a "hold" rating in a research report on Friday, April 11th. BNP Paribas raised AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 price objective for the company in a report on Thursday, January 16th. Finally, Morgan Stanley started coverage on shares of AMETEK in a report on Monday, April 14th. They set an "equal weight" rating and a $170.00 target price on the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, AMETEK has an average rating of "Moderate Buy" and an average price target of $198.60.
Get Our Latest Report on AMETEK
Insider Activity at AMETEK
In other news, Director Steven W. Kohlhagen sold 1,320 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $189.41, for a total value of $250,021.20. Following the completion of the sale, the director now owns 22,029 shares of the company's stock, valued at approximately $4,172,512.89. The trade was a 5.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas A. Amato sold 710 shares of the business's stock in a transaction dated Thursday, March 27th. The shares were sold at an average price of $176.64, for a total transaction of $125,414.40. Following the completion of the sale, the director now directly owns 10,560 shares of the company's stock, valued at $1,865,318.40. This represents a 6.30 % decrease in their position. The disclosure for this sale can be found here. 0.57% of the stock is owned by company insiders.
AMETEK Company Profile
(
Get Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.